Cargando…

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis

Long-term systemic glucocorticoids and non-specific immunosuppressants remain the mainstay of treatment for refractory scleritis, and result in serious side-effects and repeated inflammation flares. To assess the efficacy and safety of additional adalimumab, patients diagnosed with refractory non-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Binyao, Yang, Shizhao, Zhu, Lei, Peng, Xuening, He, Daquan, Tao, Tianyu, Su, Wenru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697705/ https://www.ncbi.nlm.nih.gov/pubmed/36431163 http://dx.doi.org/10.3390/jcm11226686

Ejemplares similares

Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-naïve Vogt-Koyanagi-Harada disease patients
por: Yang, Shizhao, et al.
Publicado: (2022)

Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy
por: Yang, Shizhao, et al.
Publicado: (2022)

Refractory necrotizing scleritis successfully treated with adalimumab
por: Lawuyi, Lola E., et al.
Publicado: (2016)

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
por: Park, Jihye, et al.
Publicado: (2017)

First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review
por: Chen, Binyao, et al.
Publicado: (2022)

Unraveling the Heterogeneity and Ontogeny of Dendritic Cells Using Single-Cell RNA Sequencing
por: Chen, Binyao, et al.
Publicado: (2021)

Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis
por: Bawazeer, Ahmed M., et al.
Publicado: (2011)

New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
por: Fabiani, Claudia, et al.
Publicado: (2020)

A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis
por: Zhu, Lei, et al.
Publicado: (2021)

Infliximab for the treatment of refractory scleritis
por: Doctor, Priyanka, et al.
Publicado: (2009)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2015)

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis
por: Yang, Shizhao, et al.
Publicado: (2021)

Rituximab for non-infectious Uveitis and Scleritis
por: Ng, Caleb C., et al.
Publicado: (2021)

Scleritis: Differentiating infectious from non-infectious entities
por: Murthy, Somasheila I, et al.
Publicado: (2020)

Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy
por: Gonzalez-Juanatey, Carlos, et al.
Publicado: (2012)

C-plus-plus coding conventions
por: Binko, P
Publicado: (1998)

Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review
por: Sota, Jurgen, et al.
Publicado: (2021)

Tofacitinib in Refractory Scleritis: A Case Series
por: Dey, Suvankar, et al.
Publicado: (2023)

Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
por: Alpa, Mirella, et al.
Publicado: (2015)

Comparison of health-related quality of life in patients with rheumatoid arthritis during conventional or conventional plus biological therapy in Poland
por: Bąk, Ewelina, et al.
Publicado: (2019)

Choroidal involvement in non-infectious posterior scleritis
por: Vermeirsch, Sandra, et al.
Publicado: (2021)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy
por: Pirani, Vittorio, et al.
Publicado: (2020)

Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor
por: Tanida, Satoshi, et al.
Publicado: (2023)

Systemic Cyclosporine Therapy for Scleritis: A Proposal of a Novel System to Assess the Activity of Scleritis
por: Aoki, Haruka, et al.
Publicado: (2015)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Tourette’s syndrome: Alternative approaches to a clinical case refractory to conventional therapy
por: Marinho Vaz Soares, M.I. Fonseca, et al.
Publicado: (2021)

Refractory immune thrombocytopenic purpura associated with IgM monoclonal gammopathy of undetermined significance: Successful treatment with tirabrutinib plus conventional therapies
por: Naka, Ryosuke, et al.
Publicado: (2022)

Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease
por: Ozeki, Keiji, et al.
Publicado: (2012)

Resolution of Anterior Scleritis after Periodontal Therapy
por: Guncu, Guliz Nigar, et al.
Publicado: (2011)

Infectious scleritis: Clinical spectrum and management outcomes in India
por: Pradhan, Zia Sultan, et al.
Publicado: (2013)

Infectious Scleritis: What the ID Clinician Should Know
por: Guerrero-Wooley, Richelle L, et al.
Publicado: (2018)

Efficacy and maintenance of rituximab treatment in non‐infectious scleritis
por: Vergouwen, Daphne P. C., et al.
Publicado: (2021)

PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy
por: Yamazaki, K, et al.
Publicado: (2013)

Successful use of high-dose insulin therapy in atenolol overdose refractory to conventional management
por: Karthik, Ravikanti, et al.
Publicado: (2015)

Venetoclax and Azacitidine in the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory to Conventional Therapy
por: Azad, Farhan, et al.
Publicado: (2022)

Adalimumab in Treating Refractory Livedoid Vasculopathy
por: Huang, Xiao-Wen, et al.
Publicado: (2022)

Case series: rituximab in the treatment of refractory sight-threatening scleritis
por: van Bilsen, Kiki, et al.
Publicado: (2011)

P36 A case of refractory IBD-related scleritis
por: Paterson-Brown, Lucy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_90ia48gn8iak4i9nfqooju5fjc